Neonatal hyperpigmentation: Diagnosis of familial glucocorticoid deficiency with a novel mutation in the melanocortin-2 receptor gene

Research output: Contribution to journalArticlepeer-review

1 Scopus citations

Abstract

Familial glucocorticoid deficiency (FGD), a rare autosomal recessive disorder of insensitivity to adrenocorticotropic hormone (ACTH), is characterized by isolated glucocorticoid deficiency and preserved mineralocorticoid production. The clinical features include generalized hyperpigmentation, hypoglycemia, failure to thrive, and recurrent infections. Here we describe the case of an infant who exhibited generalized hyperpigmentation and hypoglycemia. A high morning blood ACTH level and low blood cortisol level confirmed the diagnosis of FGD. The patient was found to be homozygous for a novel mutation in the melanocortin-2 receptor gene (635insC, I154H). Early initiation of corticosteroid treatment led to normalization of morning blood ACTH levels and the patient thrived, with subsequent fading of the hyperpigmentation.

Original languageEnglish
Pages (from-to)e13-e17
JournalPediatric Dermatology
Volume31
Issue number1
DOIs
StatePublished - 2014
Externally publishedYes

Fingerprint

Dive into the research topics of 'Neonatal hyperpigmentation: Diagnosis of familial glucocorticoid deficiency with a novel mutation in the melanocortin-2 receptor gene'. Together they form a unique fingerprint.

Cite this